Navigation path

Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Recombinant derivative of C3 transferase

EU orphan designation number: EU/3/08/563   
Active ingredient: Recombinant derivative of C3 transferase
Indication: Treatment of traumatic spinal cord injury
Sponsor: Vertex Pharmaceuticals (Europe) Limited
2 Kingdom Street, London W2 6BD, United Kingdom

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
09/09/2008 Orphan designation EMEA/OD/012/08 (2008)5024 of 05/09/2008
23/01/2014 Change of name and/or address of sponsor
27/01/2015 Transfer of orphan designation EMA/OD/012/08/T/01 (2015)415 of 23/01/2015
17/01/2017 Change of name and/or address of sponsor
13/03/2017 Transfer of orphan designation EMA/OD/012/08/T/02 (2017)1710 of 09/03/2017